Obstetric Surgery with High Risk of Postpartum Hemorrhage in a Jehovah’s Witness
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12763 |
Resumo: | Postpartum Hemorrhage is still the leading cause of maternal mortality. The management of patients who refuse allogeneic blood transfusion, like in the case of Jehovah’s Witnesses, is clinically and ethically challenging. We describe the case of a woman with several risk factors for major postpartum hemorrhage, specifically the presence of a giant uterine myoma. The multidisciplinary management of this patient included an elective c-section and the use of prophylactic tranexamic acid. The perioperative and peripartum care of Jehovah’s Witnesses requires specific strategies to minimize blood loss, optimize oxygen delivery and consumption, enhance hemoglobin production, correct coagulation defects and promote hemostasis. We highlight the need for a multidisciplinary approach, point-of-care testing and the use of fibrinogen concentrate and tranexamic acid, according to the patients’ informed consent. |
id |
RCAP_7d7eb3034291dc2f63cbc17278011390 |
---|---|
oai_identifier_str |
oai:ojs.www.actamedicaportuguesa.com:article/12763 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Obstetric Surgery with High Risk of Postpartum Hemorrhage in a Jehovah’s WitnessCirurgia Obstétrica com Risco Hemorrágico Major em Testemunha de JeováJehovah’s WitnessesPostpartum Hemorrhage/prevention & controlTranexamic AcidÁcido TranexâmicoHemorragia Pós-Parto/prevenção e controloTestemunhas de JeováPostpartum Hemorrhage is still the leading cause of maternal mortality. The management of patients who refuse allogeneic blood transfusion, like in the case of Jehovah’s Witnesses, is clinically and ethically challenging. We describe the case of a woman with several risk factors for major postpartum hemorrhage, specifically the presence of a giant uterine myoma. The multidisciplinary management of this patient included an elective c-section and the use of prophylactic tranexamic acid. The perioperative and peripartum care of Jehovah’s Witnesses requires specific strategies to minimize blood loss, optimize oxygen delivery and consumption, enhance hemoglobin production, correct coagulation defects and promote hemostasis. We highlight the need for a multidisciplinary approach, point-of-care testing and the use of fibrinogen concentrate and tranexamic acid, according to the patients’ informed consent.A hemorragia obstétrica continua a ser a principal causa de morbimortalidade materna, sendo que a abordagem de grávidas que recusam alotransfusão, como é o caso das Testemunhas de Jeová, coloca importantes questões médicas, éticas e legais. Reporta-se um caso de uma doente Testemunha de Jeová, submetida a cesariana com fatores de risco para hemorragia major, incluindo existência de um mioma gigante, em que se evitou a transfusão e foi utilizado ácido tranexâmico profilático. A abordagem de Testemunhas de Jeová em contexto de cirurgia obstétrica com risco hemorrágico major implica a definição de estratégias anestésico-cirúrgicas para a minimização de perdas hemorrágicas, a otimização da entrega e consumo de oxigénio, o aumento da síntese de hemoglobina, a correção de defeitos de coagulação e melhoria da hemostase. Revemos a importância do planeamento multidisciplinar, o recurso ao tromboelastrograma e a administração precoce de fibrinogénio e ácido tranexâmico, de acordo com o consentimento informado das doentes.Ordem dos Médicos2021-03-31info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfapplication/pdfimage/jpegimage/jpegapplication/pdfapplication/pdfapplication/vnd.openxmlformats-officedocument.wordprocessingml.documentapplication/pdfhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12763oai:ojs.www.actamedicaportuguesa.com:article/12763Acta Médica Portuguesa; Vol. 34 No. 4 (2021): April; 300-303Acta Médica Portuguesa; Vol. 34 N.º 4 (2021): Abril; 300-3031646-07580870-399Xreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12763https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12763/6309https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12763/11803https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12763/11804https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12763/11810https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12763/11877https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12763/11878https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12763/11969https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12763/11992Direitos de Autor (c) 2021 Acta Médica Portuguesainfo:eu-repo/semantics/openAccessCarp, MariaMaurício, SandraLança, Filipa2022-12-20T11:06:42Zoai:ojs.www.actamedicaportuguesa.com:article/12763Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T16:20:13.926342Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Obstetric Surgery with High Risk of Postpartum Hemorrhage in a Jehovah’s Witness Cirurgia Obstétrica com Risco Hemorrágico Major em Testemunha de Jeová |
title |
Obstetric Surgery with High Risk of Postpartum Hemorrhage in a Jehovah’s Witness |
spellingShingle |
Obstetric Surgery with High Risk of Postpartum Hemorrhage in a Jehovah’s Witness Carp, Maria Jehovah’s Witnesses Postpartum Hemorrhage/prevention & control Tranexamic Acid Ácido Tranexâmico Hemorragia Pós-Parto/prevenção e controlo Testemunhas de Jeová |
title_short |
Obstetric Surgery with High Risk of Postpartum Hemorrhage in a Jehovah’s Witness |
title_full |
Obstetric Surgery with High Risk of Postpartum Hemorrhage in a Jehovah’s Witness |
title_fullStr |
Obstetric Surgery with High Risk of Postpartum Hemorrhage in a Jehovah’s Witness |
title_full_unstemmed |
Obstetric Surgery with High Risk of Postpartum Hemorrhage in a Jehovah’s Witness |
title_sort |
Obstetric Surgery with High Risk of Postpartum Hemorrhage in a Jehovah’s Witness |
author |
Carp, Maria |
author_facet |
Carp, Maria Maurício, Sandra Lança, Filipa |
author_role |
author |
author2 |
Maurício, Sandra Lança, Filipa |
author2_role |
author author |
dc.contributor.author.fl_str_mv |
Carp, Maria Maurício, Sandra Lança, Filipa |
dc.subject.por.fl_str_mv |
Jehovah’s Witnesses Postpartum Hemorrhage/prevention & control Tranexamic Acid Ácido Tranexâmico Hemorragia Pós-Parto/prevenção e controlo Testemunhas de Jeová |
topic |
Jehovah’s Witnesses Postpartum Hemorrhage/prevention & control Tranexamic Acid Ácido Tranexâmico Hemorragia Pós-Parto/prevenção e controlo Testemunhas de Jeová |
description |
Postpartum Hemorrhage is still the leading cause of maternal mortality. The management of patients who refuse allogeneic blood transfusion, like in the case of Jehovah’s Witnesses, is clinically and ethically challenging. We describe the case of a woman with several risk factors for major postpartum hemorrhage, specifically the presence of a giant uterine myoma. The multidisciplinary management of this patient included an elective c-section and the use of prophylactic tranexamic acid. The perioperative and peripartum care of Jehovah’s Witnesses requires specific strategies to minimize blood loss, optimize oxygen delivery and consumption, enhance hemoglobin production, correct coagulation defects and promote hemostasis. We highlight the need for a multidisciplinary approach, point-of-care testing and the use of fibrinogen concentrate and tranexamic acid, according to the patients’ informed consent. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-03-31 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12763 oai:ojs.www.actamedicaportuguesa.com:article/12763 |
url |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12763 |
identifier_str_mv |
oai:ojs.www.actamedicaportuguesa.com:article/12763 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12763 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12763/6309 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12763/11803 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12763/11804 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12763/11810 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12763/11877 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12763/11878 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12763/11969 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12763/11992 |
dc.rights.driver.fl_str_mv |
Direitos de Autor (c) 2021 Acta Médica Portuguesa info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Direitos de Autor (c) 2021 Acta Médica Portuguesa |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf application/pdf image/jpeg image/jpeg application/pdf application/pdf application/vnd.openxmlformats-officedocument.wordprocessingml.document application/pdf |
dc.publisher.none.fl_str_mv |
Ordem dos Médicos |
publisher.none.fl_str_mv |
Ordem dos Médicos |
dc.source.none.fl_str_mv |
Acta Médica Portuguesa; Vol. 34 No. 4 (2021): April; 300-303 Acta Médica Portuguesa; Vol. 34 N.º 4 (2021): Abril; 300-303 1646-0758 0870-399X reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1817551691358142464 |